We are live on ! Find out more
BNTX icon

BioNTech
BNTX

287 hedge funds and large institutions have $3.78B invested in BioNTech in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 96 increasing their positions, 88 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

16% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 43

2% more funds holding

Funds holding: 282 → 287 (+5)

9% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 88

1% more call options, than puts

Call options by funds: $167M | Put options by funds: $165M

0.1% less ownership

Funds ownership: 17.33% → 17.23% (-0.1%)

13% less capital invested

Capital invested by funds: $4.34B → $3.78B (-$560M)

Holders
287
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.13%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
50
Increased
96
Reduced
88
Closed
43
Calls
$167M
Puts
$165M
Net Calls
+$1.86M
Net Calls Change
-$8.97M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$66.9M
2
DM
Deerfield Management
New York
+$54.6M
3
Citadel Advisors
Citadel Advisors
Florida
+$43M
4
BlackRock
BlackRock
New York
+$25.6M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$18.2M

Top Sellers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
-$104M
2
UBS AM
UBS AM
Illinois
-$74.9M
3
First Trust Advisors
First Trust Advisors
Illinois
-$44M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$31.7M
5
Morgan Stanley
Morgan Stanley
New York
-$16.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
76
Barclays
United Kingdom
$3.4M +$1.26M +13,122 +55%
LPL Financial
77
LPL Financial
California
$2.98M +$1.88M +19,648 +155%
Mackenzie Financial
78
Mackenzie Financial
Ontario, Canada
$2.78M +$788K +8,215 +38%
D.E. Shaw & Co
79
D.E. Shaw & Co
New York
$2.74M -$3.03M -31,615 -52%
CCP
80
Crocodile Capital Partners
Germany
$2.73M – – –
LSA
81
Leonteq Securities AG
Switzerland
$2.71M +$547K +5,708 +24%
Allianz Asset Management
82
Allianz Asset Management
Germany
$2.68M – – –
DZ Bank
83
DZ Bank
Germany
$2.57M +$153K +1,599 +6%
ERSOT
84
Employees Retirement System of Texas
Texas
$2.42M – – –
IMC Chicago
85
IMC Chicago
Illinois
$2.4M +$2.5M +26,030 New
BCAM
86
Boston Common Asset Management
Massachusetts
$2.38M -$633K -6,599 -20%
SGH
87
Sivik Global Healthcare
Connecticut
$2.31M +$2.4M +25,000 New
ACM
88
Advisors Capital Management
New Jersey
$2.27M +$179K +1,864 +8%
CIS
89
Capital International Sarl
California
$2.22M +$29.7K +310 +1%
US Bancorp
90
US Bancorp
Minnesota
$2.22M -$441K -4,597 -16%
PFU
91
Parus Finance (UK)
United Kingdom
$2.13M -$273K -2,848 -11%
CI
92
Capital International
California
$2.11M +$173K +1,808 +9%
OAM
93
Oppenheimer Asset Management
New York
$1.97M -$121K -1,258 -6%
GC
94
Guggenheim Capital
Illinois
$1.95M +$285K +2,971 +16%
PCMH
95
Polymer Capital Management (HK)
Hong Kong
$1.84M +$1.92M +20,000 New
CUAMC
96
China Universal Asset Management Company
China
$1.73M +$718K +7,488 +67%
HighTower Advisors
97
HighTower Advisors
Illinois
$1.66M +$26K +271 +2%
CF
98
Cantor Fitzgerald
New York
$1.65M +$1.72M +17,899 New
DCM
99
DAFNA Capital Management
California
$1.57M +$1.63M +17,000 New
QCM
100
QRG Capital Management
Illinois
$1.54M +$397K +4,144 +33%
2 3
4
5 6

BNTX Hedge Fund Activity: Q1 2024 in Review

287 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q1 2024, worth a combined $3.78B — down 13% from $4.34B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new BNTX positions and 43 closed out — a net gain of 7 holders — while 96 added to existing stakes and 88 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $66.9M. The largest seller was Temasek Holdings, cutting an estimated $104M.

  • 287 institutional investors held BioNTech (BNTX) as of Q1 2024, up from 282 in Q4 2023.
  • Funds reported $3.78B of BioNTech stock for Q1 2024, down 13% quarter-over-quarter.
  • 50 funds opened new BioNTech positions in Q1 2024 and 43 closed out, a net change of +7 holders.
  • The largest BioNTech buyer in Q1 2024 was Fidelity Investments, an estimated $66.9M added.
  • The largest BioNTech seller in Q1 2024 was Temasek Holdings, an estimated $104M sold.

Based on aggregated 13F filings for Q1 2024.